S. Ashraf Imam

724 total citations
25 papers, 530 citations indexed

About

S. Ashraf Imam is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, S. Ashraf Imam has authored 25 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in S. Ashraf Imam's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Immunotherapy and Immune Responses (5 papers) and Glycosylation and Glycoproteins Research (4 papers). S. Ashraf Imam is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Immunotherapy and Immune Responses (5 papers) and Glycosylation and Glycoproteins Research (4 papers). S. Ashraf Imam collaborates with scholars based in United States, United Kingdom and Thailand. S. Ashraf Imam's co-authors include Clive R. Taylor, Lillian Young, Richard J. Côté, Benjaporn Chaiwun, Shan-Rong Shi, Susan Groshen, Baisakhi Saha, Wesley Y. Naritoku, Denice Tsao‐Wei and Lawrence W. Jones and has published in prestigious journals such as PLoS ONE, Cancer and Analytical Biochemistry.

In The Last Decade

S. Ashraf Imam

25 papers receiving 493 citations

Peers

Countries citing papers authored by S. Ashraf Imam

Since Specialization

Citations

This map shows the geographic impact of S. Ashraf Imam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ashraf Imam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ashraf Imam more than expected).

Fields of papers citing papers by S. Ashraf Imam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ashraf Imam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ashraf Imam. The network helps show where S. Ashraf Imam may publish in the future.

Co-authorship network of co-authors of S. Ashraf Imam

This figure shows the co-authorship network connecting the top 25 collaborators of S. Ashraf Imam. A scholar is included among the top collaborators of S. Ashraf Imam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ashraf Imam. S. Ashraf Imam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stromal Response to Prostate Cancer: Nanotechnology-Based Detection of Thioredoxin-Interacting Protein Partners Distinguishes Prostate Cancer Associated Stroma from That of Benign Prostatic Hyperplasia 2013 ·PLoS ONE ·(unknown), Jennifer Linehan, (unknown), S. Ashraf Imam, David Smith, Sofia Loera, Timothy G. Wilson, Steven S. Smith	6
2	Biomarker Identification with Ligand-Targeted Nucleoprotein Assemblies 2011 ·Nanomedicine ·(unknown), Laura E. Crocitto, (unknown), Sofia Loera, Lawrence M. Weiss, S. Ashraf Imam, Timothy G. Wilson, Steven S. Smith	22
3	Tissue engineered tumor models 2010 ·Biotechnic & Histochemistry ·M. Ingram, (unknown), (unknown), S. Ashraf Imam, Roscoe Atkinson, Henry C. Ho, (unknown)	20
4	Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARβ2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens 2009 ·Analytical Biochemistry ·Gerald Zon, Melissa Barker, (unknown), Susan Groshen, Lawrence W. Jones, S. Ashraf Imam, Victoria L. Boyd	12
5	J1‐31 protein expression in astrocytes and astrocytomas 2008 ·Neuropathology ·Shanop Shuangshoti, Paul S. Thorner, Preecha Ruangvejvorachai, Baisakhi Saha, Susan Groshen, Clive R. Taylor, Sudarshan K. Malhotra, S. Ashraf Imam	5
6	Unmethylated E‐Cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone 2008 ·The Prostate ·Baisakhi Saha, (unknown), Denice Tsao‐Wei, Wesley Y. Naritoku, Susan Groshen, Ram H. Datar, Lawrence W. Jones, S. Ashraf Imam	20
7	Overexpression of E-cadherin protein in metastatic breast cancer cells in bone. 2008 ·PubMed ·Baisakhi Saha, Benjaporn Chaiwun, (unknown), Denice Tsao‐Wei, Susan Groshen, Wesley Y. Naritoku, S. Ashraf Imam	32
8	Telomerase and Markers of Cellular Proliferation Are Associated With the Progression of Cervical Intraepithelial Neoplasia Lesions 2007 ·International Journal of Gynecological Pathology ·Baisakhi Saha, Benjaporn Chaiwun, Denice Tsao‐Wei, Susan L. Groshen, Wesley Y. Naritoku, Roscoe D. Atkinson, Clive R. Taylor, S. Ashraf Imam	9
9	Overexpression of E‐cadherin and β‐Catenin proteins in metastatic prostate cancer cells in bone 2007 ·The Prostate ·Baisakhi Saha, (unknown), (unknown), (unknown), Denice Tsao‐Wei, Wesley Y. Naritoku, Susan Groshen, Lawrence W. Jones, S. Ashraf Imam	49
10	LEA.135 expression: An independent and favorable prognostic biomarker for patients with primary invasive breast cancer 2000 ·International Journal of Cancer ·Dongxin Liu, Wesley Y. Naritoku, Denice Tsao‐Wei, Susan Groshen, (unknown), Clive R. Taylor, Richard J. Côté, S. Ashraf Imam	1
11	Analysis of Telomerase Activity in Ovarian Cystadenomas, Low-Malignant-Potential Tumors, and Invasive Carcinomas 1999 ·Gynecologic Oncology ·Ram H. Datar, Wesley Y. Naritoku, (unknown), (unknown), Susan Groshen, (unknown), S. Ashraf Imam	16
12	Telomerase activity 1999 ·Cancer ·Wesley Y. Naritoku, Ram H. Datar, (unknown), Susan L. Groshen, Clive R. Taylor, S. Ashraf Imam	5
13	Telomeric DNA: Marker for human prostate cancer development? 1998 ·The Prostate ·Mustafa Özen, S. Ashraf Imam, Ram H. Datar, Asha S. Multani, (unknown), Leland W.K. Chung, Andrew C. von Eschenbach, Sen Pathak	9
14	A sialoglycoprotein (LEA.135) associated with favourable prognosis of patients with lymph node-negative primary breast carcinoma. 1996 ·PubMed ·S. Ashraf Imam, Benjaporn Chaiwun, (unknown), (unknown), (unknown), (unknown), Humberto Torloni, (unknown), Taylor Cr	1
15	Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: Androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques 1994 ·Human Pathology ·Clive R. Taylor, Shan-Rong Shi, Benjaporn Chaiwun, Lillian Young, S. Ashraf Imam, Richard J. Côté	233
16	Reply 1994 ·Human Pathology ·Clive R. Taylor, Shan‐Rong Shi, Benjaporn Chaiwun, Lillian Young, S. Ashraf Imam, Richard J. Côté	12
17	Development of tumorigenicity and rearrangement of chromosome 1 correlates with down-regulation of cell-surface glycoproteins in human mammary carcinoma cell line. 1994 ·PubMed ·S. Ashraf Imam, Sen Pathak, (unknown), Aysun Yilmaz, (unknown)	1
18	Identification of a cell-surface antigen (LEA.135) associated with favorable prognosis in human breast cancer. 1993 ·PubMed ·S. Ashraf Imam, (unknown), (unknown), Robert D. Cardiff, Clive R. Taylor	5
19	Detection by a human monoclonal antibody of a glycoprotein associated with malignant proliferation of mammary epithelial cells 1991 ·British Journal of Cancer ·S. Ashraf Imam, (unknown), CR Taylor	1
20	Effect of emetine hydrochloride on cysts of amoebae in presence of trypsin and lysozyme. 1969 ·PubMed ·S. Ashraf Imam, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact